{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:51:51Z","timestamp":1773661911401,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971940"],"award-info":[{"award-number":["81971940"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2314-B-006-089"],"award-info":[{"award-number":["108-2314-B-006-089"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2320-B-006-039-MY3"],"award-info":[{"award-number":["108-2320-B-006-039-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007750","name":"National Cheng Kung University","doi-asserted-by":"publisher","award":["CMNCKU10817"],"award-info":[{"award-number":["CMNCKU10817"]}],"id":[{"id":"10.13039\/501100007750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007750","name":"National Cheng Kung University","doi-asserted-by":"publisher","award":["NCKUEDA10803"],"award-info":[{"award-number":["NCKUEDA10803"]}],"id":[{"id":"10.13039\/501100007750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jmii.2022.06.004","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T13:17:36Z","timestamp":1657113456000},"page":"20-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Interdependence of glycemic and lipid modulation in cured chronic hepatitis C patients by direct-acting antiviral agents"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9331-9018","authenticated-orcid":false,"given":"Pin-Nan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5411-8424","authenticated-orcid":false,"given":"Hung-Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Che","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0825-3769","authenticated-orcid":false,"given":"Yen-Cheng","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1341-9930","authenticated-orcid":false,"given":"Sin-Tian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8233-6648","authenticated-orcid":false,"given":"Dyoness Charmaine","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9538-7188","authenticated-orcid":false,"given":"Hung-Chih","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Chih","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0622-211X","authenticated-orcid":false,"given":"Kung-Chia","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2022.06.004_bib1","first-page":"3","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection","volume":"3","author":"Cacoub","year":"2016","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.jmii.2022.06.004_bib2","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","volume":"394","author":"Spearman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2022.06.004_bib3","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(18)32111-1","article-title":"Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study","volume":"393","author":"Carrat","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2022.06.004_bib4","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/cid\/cix1106","article-title":"Hepatitis C in patients with minimal or No hepatic fibrosis: the impact of treatment and sustained virologic response on patient-reported outcomes","volume":"66","author":"Younossi","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2022.06.004_bib5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/apt.15102","article-title":"Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes","volume":"49","author":"Li","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jmii.2022.06.004_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.4765","article-title":"Assessing the safety of direct-acting antiviral agents for hepatitis C","volume":"2","author":"McGlynn","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jmii.2022.06.004_bib7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1053\/j.gastro.2018.11.022","article-title":"Direct-acting antiviral therapy for HCV infection is associated with a reduced risk of cardiovascular disease events","volume":"156","author":"Butt","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jmii.2022.06.004_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.atherosclerosis.2020.01.010","article-title":"Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: a prospective multicentre study","volume":"296","author":"Adinolfi","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jmii.2022.06.004_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4239\/wjd.v5.i1.52","article-title":"Hepatitis C virus infection and insulin resistance","volume":"5","author":"Bose","year":"2014","journal-title":"World J Diabetes"},{"key":"10.1016\/j.jmii.2022.06.004_bib10","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0002-9440(10)63408-6","article-title":"Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3","volume":"165","author":"Kawaguchi","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jmii.2022.06.004_bib11","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1128\/JVI.01672-07","article-title":"Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt\/protein kinase B signaling pathway for insulin resistance","volume":"82","author":"Banerjee","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.jmii.2022.06.004_bib12","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/hep.22269","article-title":"Hepatitis C virus infection: molecular pathways to metabolic syndrome","volume":"47","author":"Sheikh","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jmii.2022.06.004_bib13","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jhep.2008.12.029","article-title":"HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters","volume":"50","author":"Kasai","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jmii.2022.06.004_bib14","first-page":"278","article-title":"Molecular mechanism of hepatitis C virus-induced glucose metabolic disorders","volume":"2","author":"Shoji","year":"2011","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jmii.2022.06.004_bib15","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3748\/wjg.v22.i6.1953","article-title":"Hepatitis C virus relies on lipoproteins for its life cycle","volume":"22","author":"Grassi","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jmii.2022.06.004_bib16","series-title":"Tracking hepatitis C virus interactions with the hepatic lipid metabolism","first-page":"889","author":"Vieyres","year":"2020"},{"key":"10.1016\/j.jmii.2022.06.004_bib17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/ncb1631","article-title":"The lipid droplet is an important organelle for hepatitis C virus production","volume":"9","author":"Miyanari","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jmii.2022.06.004_bib18","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1074\/jbc.M110.175018","article-title":"Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome","volume":"286","author":"Merz","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmii.2022.06.004_bib19","first-page":"e01617","article-title":"Hepatitis C virus infection induces hepatic expression of NF-\u03baB-Inducing kinase and lipogenesis by downregulating miR-122","volume":"10","author":"Lowey","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.jmii.2022.06.004_bib20","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1128\/JVI.01653-14","article-title":"Hepatitis C virus attenuates mitochondrial lipid \u03b2-oxidation by downregulating mitochondrial trifunctional-protein expression","volume":"89","author":"Amako","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.jmii.2022.06.004_bib21","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3748\/wjg.v27.i13.1267","article-title":"Metabolic complications of hepatitis C virus infection","volume":"27","author":"Chaudhari","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jmii.2022.06.004_bib22","first-page":"113","article-title":"Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?","volume":"6","author":"Lim","year":"2014","journal-title":"Hepat Med"},{"key":"10.1016\/j.jmii.2022.06.004_bib23","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/gutjnl-2017-313832","article-title":"Favouring modulation of circulating lipoproteins and lipid loading capacity by direct antiviral agents grazoprevir\/elbasvir or ledipasvir\/sofosbuvir treatment against chronic HCV infection","volume":"67","author":"Sun","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jmii.2022.06.004_bib24","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.2337\/dc07-0358","article-title":"Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study","volume":"30","author":"Song","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jmii.2022.06.004_bib25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nrendo.2011.235","article-title":"The emerging role of HDL in glucose metabolism","volume":"8","author":"Drew","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jmii.2022.06.004_bib26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fphar.2015.00258","article-title":"HDL and glucose metabolism: current evidence and therapeutic potential","volume":"6","author":"Siebel","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jmii.2022.06.004_bib27","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2174\/1389450116666150727115544","article-title":"HDL as a target for glycemic control","volume":"18","author":"Waldman","year":"2017","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jmii.2022.06.004_bib28","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.3390\/jcm9092702","article-title":"Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis","volume":"9","author":"Graf","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jmii.2022.06.004_bib29","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1038\/s41598-018-26293-9","article-title":"Eradication of hepatitis C virus is associated with the attenuation of steatosis as evaluated using a controlled attenuation parameter","volume":"8","author":"Shimizu","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmii.2022.06.004_bib30","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.3748\/wjg.v23.i13.2355","article-title":"Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b","volume":"23","author":"Endo","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jmii.2022.06.004_bib31","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1172\/JCI129188","article-title":"\u03b2 Cell dysfunction during progression of metabolic syndrome to type 2 diabetes","volume":"129","author":"Hudish","year":"2019","journal-title":"J Clin Invest"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118222000950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118222000950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:29:27Z","timestamp":1761658167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118222000950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1684118222000950"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2022.06.004","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interdependence of glycemic and lipid modulation in cured chronic hepatitis C patients by direct-acting antiviral agents","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2022.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}